lyle mcdonald glp 1 An underappreciated fact about the GLP-1s is that there is a large amount of variability among the different compounds. With the earlier drugs, some percentage lost weight, some lost none and some Ep. #415: Lyle McDonald on

K.ArodaV

[3] Next-Generation Dual and Multi-Targeted Therapies on the Rise Amycretin: A Promising Dual GLP-1/Amylin Receptor Agonist Also making headlines at ADA 2025 was Amycretin (NNC0487-0111), a novel, unimolecular GLP-1 and amylin receptor agonist under development by Novo Nordisk

Because of these changes, many clinicians encourage people using GLP-1 medications to be intentional about hydration , rather than relying only on thirst cues

A: In most cases, yes

Experimental studies have examined its activity in models involving connective tissue repair, musculoskeletal recovery, and gastrointestinal biology

Article Topics Joshua Barney Deputy Public Information Officer